ElectroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
ElectroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will be participating in the Lytham Partners Fall 2023 Investor Conference taking place virtually on Tuesday, October 17, 2023.
新澤西州羅克韋，2023年10月5日(環球網)--商業生物電子醫藥和保健公司電芯公司(納斯達克：ECOR)今天宣佈，公司首席執行官丹·戈德伯格將參加2023年10月17日(星期二)舉行的Lytham Partners Fall 2023投資者大會。
1x1 Meetings
1x1會議
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register at
管理層將在整個活動期間參加虛擬的一對一會議。要安排與管理層的會議，請通過1x1@lythampartners.com聯繫Lytham Partners，或通過以下方式註冊
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation ("nVNS") technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
關於電子核心公司
Electrcore，Inc.是一家商業階段的生物電子藥物和健康公司，致力於通過其非侵入性迷走神經刺激(“nVNS”)技術平臺改善健康。我們的重點是用於管理和治療某些醫療條件的醫療設備的商業化，以及利用NVNS提供的消費產品，以促進美國和部分海外市場的整體福祉和人類表現。
For more information, visit .
有關更多資訊，請訪問。
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
聯繫方式：
EcoR投資者關係
(973)302-9253
郵箱：Investors@Electric core.com
譯文內容由第三人軟體翻譯。